- Report of Foreign Issuer (6-K)
12 8월 2010 - 9:00PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2010
Commission File Number: 000-51606
VIMICRO
INTERNATIONAL CORPORATION
15/F Shining Tower
No. 35 Xueyuan Road, Haidian District
Beijing 100191, Peoples Republic of China
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
X
Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule
101(b)(1):
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes
No
X
If Yes is marked,
indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):
82-
N/A
This Form 6-K is being
incorporated by reference into the registrants Registration Statement on Form F-3 (File No. 333-166948), filed with the Securities and Exchange Commission on May 19, 2010.
Second Quarter 2010 Financial Results
Vimicro International Corporation (NASDAQ: VIMC) (Vimicro or the Company), a leading multimedia semiconductor and solution
provider, announced its financial results for the second quarter ended June 30, 2010.
Second Quarter 2010
Net revenue in the second quarter of 2010 was $26.4 million, an increase of 31% compared to $20.1 million in the first quarter of 2010 and 41% from the
$18.7 million in the second quarter of 2009. The growth in revenue reflects increases in demand for the Companys notebook camera processor and mobile multimedia products. Gross margin improved to 34.3% compared to 33.6% in the previous quarter
driven by continued strength in notebook products and a favorable mix of higher margin mobile products.
Second quarter 2010
net loss, prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP), was $4.3 million, which included $0.9 million in share-based compensation expense and $1.0 million IP/Software purchase expense. After excluding
loss attributable to non-controlling interest, net loss attributed to Vimicro was $2.8 million in the second quarter, or $0.08 loss per ADS (each representing four ordinary shares), compared to a net loss of $4.4 million, or $0.12 loss per
ADS, in the first quarter of 2010.
2
Non-GAAP Measures
To supplement the consolidated financial statements presented in accordance with GAAP, Vimicro uses non-GAAP measures of non-GAAP
(loss)/income from operations, non-GAAP net (loss)/income attributed to Vimicro International Corporation and non-GAAP diluted net (loss)/income per ADS, which are adjusted from the most directly comparable financial measures calculated and
presented in accordance with GAAP to exclude amortization of share-based compensation expenses. These non-GAAP financial measures are provided to enhance investors overall understanding of the companys financial performance as they
exclude share-based expenses that are not expected to result in future cash payments. The non-GAAP measures should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for or superior to
GAAP results. A limitation of using these non-GAAP financial measures is that these non-GAAP measures exclude share-based compensation charges that have been and will continue to be significant recurring expenses in our business for the foreseeable
future. We compensate for these limitations by providing the relevant disclosure of our share-based compensation charges in our reconciliations to the GAAP measures. For more information on the non-GAAP financial measures, please see the tables
captioned Reconciliation of non- GAAP results of operations measures to the nearest comparable GAAP measures set forth at the end of this release.
Vimicro believes that both management and investors benefit from referring to these non-GAAP measures in assessing the performance of Vimicros
liquidity and when planning and forecasting future periods. These non-GAAP financial measures also facilitate managements internal comparisons to Vimicros historical liquidity. Vimicro computes its non-GAAP financial measures using the
same consistent method from quarter to quarter. The accompanying tables have more details on the GAAP financial measures that are most comparable to non-GAAP financial measures and the related reconciliations between financial measures.
Currency Translation
This announcement contains translations of certain RMB amounts into U.S. dollars. Unless otherwise noted, all translations from RMB to
U.S. dollars are based on the applicable exchange rates quoted by the Bank of China as of June 30, 2010, which was RMB 6.7909 to $1.00.
3
Vimicro International Corporation
Consolidated Balance Sheets
(Amounts
expressed in thousands of U.S. dollars, except number of share data)
|
|
|
|
|
|
|
|
|
6/30/2010
|
|
|
12/31/2009
|
|
|
|
(unaudited)
|
|
|
(audited)
|
|
Assets
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
60,354
|
|
|
84,510
|
|
Short-term time deposits
|
|
44,177
|
|
|
43,935
|
|
Restricted cash
|
|
869
|
|
|
132
|
|
Marketable equity securities
|
|
819
|
|
|
543
|
|
Accounts receivable, net of provision for doubtful accounts
|
|
11,638
|
|
|
9,462
|
|
Inventories
|
|
16,739
|
|
|
8,804
|
|
Prepayments and other current assets
|
|
5,322
|
|
|
4,155
|
|
Deferred tax assets
|
|
3
|
|
|
3
|
|
|
|
|
|
|
|
|
Total current assets
|
|
139,921
|
|
|
151,544
|
|
Property, equipment and software, net
|
|
9,047
|
|
|
9,015
|
|
land use rights
|
|
20,291
|
|
|
10,905
|
|
Intangible assets, net
|
|
3,348
|
|
|
3,819
|
|
Goodwill
|
|
2,031
|
|
|
2,019
|
|
Other assets
|
|
968
|
|
|
973
|
|
|
|
|
|
|
|
|
Total assets
|
|
175,606
|
|
|
178,275
|
|
|
|
|
|
|
|
|
Liabilities and Shareholders Equity
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
Accounts payable
|
|
7,975
|
|
|
4,958
|
|
Notes payable
|
|
386
|
|
|
|
|
Taxes payable
|
|
1,226
|
|
|
879
|
|
Advances from customers
|
|
571
|
|
|
649
|
|
Accrued expenses and other current liabilities
|
|
4,927
|
|
|
5,900
|
|
Deferred government grants
|
|
2,761
|
|
|
3,844
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
17,846
|
|
|
16,230
|
|
Non-Current liabilities:
|
|
|
|
|
|
|
Deferred tax liabilities
|
|
99
|
|
|
196
|
|
Product warranty
|
|
49
|
|
|
25
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
17,994
|
|
|
16,451
|
|
|
|
|
Shareholders equity:
|
|
|
|
|
|
|
Ordinary shares, $0.0001 par value, 500,000,000 shares authorized, 147,724,068 and 147,643,168 shares issued and outstanding as
of June 30, 2010 and December 31, 2009, respectively
|
|
15
|
|
|
15
|
|
Additional paid-in capital
|
|
154,390
|
|
|
151,672
|
|
Treasury stock
|
|
(2,664
|
)
|
|
(2,664
|
)
|
Accumulated other comprehensive income
|
|
10,549
|
|
|
9,967
|
|
Accumulated deficit
|
|
(42,989
|
)
|
|
(35,786
|
)
|
Statutory reserve
|
|
2,782
|
|
|
2,782
|
|
|
|
|
|
|
|
|
Total shareholders equity attributable to Vimicro International Corporation
|
|
122,083
|
|
|
125,986
|
|
Noncontrolling interest
|
|
35,529
|
|
|
35,838
|
|
|
|
|
|
|
|
|
Total shareholders equity
|
|
157,612
|
|
|
161,824
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity
|
|
175,606
|
|
|
178,275
|
|
|
|
|
|
|
|
|
4
Vimicro International Corporation
Consolidated Statement Of Operations And Comprehensive Income
(Amounts expressed in thousands of U.S. dollars, except number of share data)
|
|
|
|
|
|
|
|
|
|
|
|
2010 Q2
|
|
|
2010 Q1
|
|
|
2009 Q2
|
|
|
|
(unaudited)
|
|
|
(unaudited)
|
|
|
(unaudited)
|
|
Net revenue
|
|
26,368
|
|
|
20,110
|
|
|
18,717
|
|
Cost of revenue
|
|
(17,314
|
)
|
|
(13,351
|
)
|
|
(13,393
|
)
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
9,054
|
|
|
6,759
|
|
|
5,324
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
Research and development, net
|
|
(8,801
|
)
|
|
(8,750
|
)
|
|
(7,371
|
)
|
Selling and marketing
|
|
(1,969
|
)
|
|
(1,457
|
)
|
|
(1,129
|
)
|
General and administrative
|
|
(3,161
|
)
|
|
(3,208
|
)
|
|
(6,019
|
)
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
(13,931
|
)
|
|
(13,415
|
)
|
|
(14,519
|
)
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
(4,877
|
)
|
|
(6,656
|
)
|
|
(9,195
|
)
|
|
|
|
|
Other income/(expense):
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
292
|
|
|
309
|
|
|
387
|
|
Foreign exchange (loss)/gain, net
|
|
54
|
|
|
(35
|
)
|
|
2
|
|
Gain on disposal of available-for-sale securities
|
|
|
|
|
|
|
|
512
|
|
Others, net
|
|
750
|
|
|
861
|
|
|
53
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes
|
|
(3,781
|
)
|
|
(5,521
|
)
|
|
(8,241
|
)
|
|
|
|
|
Income taxes expense
|
|
(518
|
)
|
|
(172
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
(4,299
|
)
|
|
(5,693
|
)
|
|
(8,241
|
)
|
|
|
|
|
|
|
|
|
|
|
Less: (loss)/income attributable to non-controlling interest
|
|
(1,504
|
)
|
|
(1,285
|
)
|
|
135
|
|
|
|
|
|
|
|
|
|
|
|
Loss attributed to Vimicro International Corporation
|
|
(2,795
|
)
|
|
(4,408
|
)
|
|
(8,376
|
)
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment
|
|
458
|
|
|
33
|
|
|
73
|
|
Unrealized gain on marketable equity securities
|
|
263
|
|
|
13
|
|
|
315
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss
|
|
(3,578
|
)
|
|
(5,647
|
)
|
|
(7,853
|
)
|
Less: comprehensive (loss)/income attributable to non-controlling interest
|
|
(1,319
|
)
|
|
(1,285
|
)
|
|
188
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss attributable to Vimicro International Corporation
|
|
(2,259
|
)
|
|
(4,361
|
)
|
|
(8,041
|
)
|
|
|
|
|
|
|
|
|
|
|
Loss per share
|
|
|
|
|
|
|
|
|
|
Basic
|
|
(0.02
|
)
|
|
(0.03
|
)
|
|
(0.06
|
)
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
(0.02
|
)
|
|
(0.03
|
)
|
|
(0.06
|
)
|
|
|
|
|
|
|
|
|
|
|
Loss per ADS
|
|
|
|
|
|
|
|
|
|
Basic
|
|
(0.08
|
)
|
|
(0.12
|
)
|
|
(0.24
|
)
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
(0.08
|
)
|
|
(0.12
|
)
|
|
(0.24
|
)
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of ordinary shares outstanding
|
|
|
|
|
|
|
|
|
|
Basic
|
|
147,690,245
|
|
|
147,657,701
|
|
|
138,706,574
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
147,690,245
|
|
|
147,657,701
|
|
|
138,706,574
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of ADS outstanding
|
|
|
|
|
|
|
|
|
|
Basic
|
|
36,922,561
|
|
|
36,914,425
|
|
|
34,676,643
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
36,922,561
|
|
|
36,914,425
|
|
|
34,676,643
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Components of share-based compensation expenses
are included in the following expense captions:
|
|
|
|
|
|
|
|
|
|
R&D
|
|
(422
|
)
|
|
(532
|
)
|
|
(1,634
|
)
|
S&M
|
|
(50
|
)
|
|
(56
|
)
|
|
(70
|
)
|
G&A
|
|
(477
|
)
|
|
(575
|
)
|
|
(3,963
|
)
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
(949
|
)
|
|
(1,163
|
)
|
|
(5,667
|
)
|
5
Reconciliations of non-GAAP results of operations measures to the nearest comparable GAAP measures
(*)
(Amounts expressed in thousands of U.S. dollars, except per share data, unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
June 30,
2010
|
|
|
Three months ended
March 31,
2010
|
|
|
Three months ended
June 30,
2009
|
|
|
|
GAAP
Result
|
|
|
Adjustment
|
|
Non-GAAP
Results
|
|
|
GAAP
Result
|
|
|
Adjustment
|
|
Non-GAAP
Results
|
|
|
GAAP
Result
|
|
|
Adjustment
|
|
Non-GAAP
Results
|
|
Loss from operations
|
|
(4,877
|
)
|
|
949
|
|
(3,928
|
)
|
|
(6,656
|
)
|
|
1,163
|
|
(5,493
|
)
|
|
(9,195
|
)
|
|
5,667
|
|
(3,528
|
)
|
Loss attributed to Vimicro International Corporation
|
|
(2,795
|
)
|
|
949
|
|
(1,846
|
)
|
|
(4,408
|
)
|
|
1,163
|
|
(3,245
|
)
|
|
(8,376
|
)
|
|
5,667
|
|
(2,709
|
)
|
Diluted loss per ADS
|
|
(0.08
|
)
|
|
0.03
|
|
(0.05
|
)
|
|
(0.12
|
)
|
|
0.03
|
|
(0.09
|
)
|
|
(0.24
|
)
|
|
0.16
|
|
(0.08
|
)
|
(*)
|
The adjustment is to exclude non-cash for share-based compensation for employees and non-employees.
|
6
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
|
|
|
|
VIMICRO INTERNATIONAL CORPORATION
|
|
|
By:
|
|
/
S
/ J
OHN
Z
HONGHAN
D
ENG
|
Name:
|
|
John Zhonghan Deng
|
Title:
|
|
Chairman and Chief Executive Officer
|
Date: August 12, 2010
7
(MM) (NASDAQ:VIMC)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
(MM) (NASDAQ:VIMC)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024